Patents by Inventor Shuji Saitoh

Shuji Saitoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240087840
    Abstract: An electron microscope includes an irradiation optical system that irradiates a specimen with an electron beam, a specimen stage that supports the specimen, an image forming optical system that forms an image of electrons transmitted through the specimen, an imaging apparatus that captures an image formed by the image forming optical system, and a control unit that controls inclination of the specimen with respect to an incident direction of the electron beam. The irradiation optical system includes an aperture that cuts off a part of the electron beam to be irradiated to the specimen. The control unit acquires an image including Kikuchi bands that appear in a shadow region of the aperture, detects the Kikuchi bands in the shadow region of the aperture in the image, and controls inclination of the specimen with respect to the incident direction of the electron beam, based on the detected Kikuchi bands.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 14, 2024
    Inventors: Motofumi Saitoh, Shuji Kawai
  • Patent number: 11020472
    Abstract: The present invention relates to novel recombinant swinepox viruses and their use in vaccine compositions. The recombinant swinepox viruses of the invention are doubly defective for IL18bp and TK genes, and comprise at least one foreign gene cloned into defective TK gene sequence. The invention is particularly suited to produce swine vaccines, particularly for vaccinating swine against PCV2 infection.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: June 1, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Takanori Sato, Shuji Saitoh, Yasutoshi Komiya
  • Patent number: 10821170
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: November 3, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Patent number: 10717967
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 21, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Patent number: 10711254
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 14, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Patent number: 10711255
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 14, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Patent number: 10704028
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 7, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Publication number: 20190307876
    Abstract: The present invention relates to novel recombinant swinepox viruses and their use in vaccine compositions. The recombinant swinepox viruses of the invention are doubly defective for IL18bp and TK genes, and comprise at least one foreign gene cloned into defective TK gene sequence. The invention is particularly suited to produce swine vaccines, particularly for vaccinating swine against PCV2 infection.
    Type: Application
    Filed: June 9, 2017
    Publication date: October 10, 2019
    Inventors: TAKANORI SATO, SHUJI SAITOH, YASUTOSHI KOMIYA
  • Publication number: 20190144836
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 16, 2019
    Inventors: Saeki Yukari, Shuji Saitoh
  • Publication number: 20190144835
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 16, 2019
    Inventors: SAEKI YUKARI, SHUJI SAITOH
  • Publication number: 20190136208
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 9, 2019
    Inventors: SAEKI YUKARI, SHUJI SAITOH
  • Publication number: 20190136209
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 9, 2019
    Inventors: SAEKI YUKARI, SHUJI SAITOH
  • Patent number: 10246685
    Abstract: The present invention relates to recombinant MDV1 viruses and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: April 2, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Yukari Ishihara, Motoyuki Esaki, Shuji Saitoh
  • Patent number: 10202582
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: February 12, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Patent number: 10188720
    Abstract: The present invention relates recombinant viruses and the uses thereof. More particularly, the invention relates to novel recombinant Marek's disease viruses encoding polypeptide(s) of interest, and their use to express or deliver such polypeptides to animals, particularly poultry. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: January 29, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Motoyuki Esaki, Shuji Saitoh, Takanori Sato
  • Publication number: 20180187164
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: June 29, 2016
    Publication date: July 5, 2018
    Inventors: SAEKI YUKARI, SHUJI SAITOH
  • Publication number: 20180016559
    Abstract: The present invention relates to recombinant MDV1 viruses and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: January 29, 2016
    Publication date: January 18, 2018
    Inventors: Yukari Ishihara, Motoyuki Esaki, Shuji Saitoh
  • Publication number: 20160220657
    Abstract: The present invention relates recombinant viruses and the uses thereof. More particularly, the invention relates to novel recombinant Marek's disease viruses encoding polypeptide(s) of interest, and their use to express or deliver such polypeptides to animals, particularly poultry. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Application
    Filed: September 5, 2014
    Publication date: August 4, 2016
    Inventors: Motoyuki Esaki, Shuji Saitoh, Takanori Sato
  • Patent number: 7538201
    Abstract: A recombinant herpesvirus (excluding infectious laryngotracheitis virus) having a DNA that encodes a polypeptide comprising 429 amino acids at the amino terminal end of a protein encoded by the gB gene of infectious laryngotracheitis virus or a polypeptide in which one or a plurality of amino acids have been deleted, added, or substituted in said polypeptide.
    Type: Grant
    Filed: March 9, 2005
    Date of Patent: May 26, 2009
    Assignee: Zeon Corporation
    Inventors: Takashi Okuda, Shuji Saitoh, Sakiko Saeki
  • Patent number: 7348422
    Abstract: A DNA coding for a fusion protein comprising a polypeptide having the antigenicity of Mycoplasma gallisepticum and a polypeptide derived from Herpesvirus outer membrane protein, in which the polypeptide derived from the outer membrane protein has been ligated with the polypeptide having the antigenicity of Mycoplasma gallisepticum at the N terminus thereof, is prepared. The DNA is inserted into a region non-essential to growth of Avipox virus and the resulting recombinant Avipox virus is provided as a more potent recombinant virus as an anti-Mycoplasma vaccine.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: March 25, 2008
    Assignee: Zeon Corporation
    Inventors: Shuji Saitoh, Yoshinari Tsuzaki, Noboru Yanagida